- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
- GeneType and Humanise Health host “Know Your Risk” Event
- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
- Appendix 4C & Quarterly Business Update – March 2024
- Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
- Genetic Technologies Announces $2 Million Registered Direct Offering
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
- GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
- GTG to pilot GeneType in Breast Screen centers across the U.S.
- EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
More ▼
Key statistics
On Friday, Genetic Technologies Ltd (DU8:STU) closed at 0.055, 10.00% above its 52-week low of 0.05, set on Dec 13, 2023.
52-week range
Open | 0.055 |
---|---|
High | 0.055 |
Low | 0.055 |
Bid | 0.059 |
Offer | 0.111 |
Previous close | 0.055 |
Average volume | 1.00k |
---|---|
Shares outstanding | 132.22m |
Free float | 118.56m |
P/E (TTM) | -- |
Market cap | 13.22m AUD |
EPS (TTM) | -0.1126 AUD |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼